AcroMeta gain a LOA for USD 6.1mln design and build works
AcroMeta Group Limited, an established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biotechnology, pharmaceutical, research and academia sectors, has received a letter of award (“LOA”) for the design and build of laboratory and office space worth approximately S USD6.1 million from a global clinical research organisation that helps […]
Neomorph appoints Bell Zhong as Chief Financial Officer
Neomorph, Inc., a venture backed biotechnology company solving critical problems in human health through the discovery and development of innovative new medicines against ‘undruggable targets,’ recently announced the appointment of Bell Zhong as the company’s Chief Financial Officer. Mr. Zhong brings to Neomorph more than 17 years of investment banking and corporate finance leadership experience […]
Vaderis Therapeutics AG announces Initiation of Clinical PoC trial in HHT
Vaderis Therapeutics AG (Vaderis), one of the clinical stage biotechnology company focused on developing treatments for rare diseases associated with vascular malformations, recently announced its emergence from stealth and initiation of its INSIGHT proof-of-concept (PoC) clinical trial in patients suffering from Hereditary Haemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu Syndrome. Vaderis was established in 2019 […]
